HomeVERA • NASDAQ
add
Vera Therapeutics Inc
Previous close
$38.69
Day range
$38.40 - $40.25
Year range
$6.07 - $50.78
Market cap
2.16B USD
Avg Volume
1.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.03M | -19.51% |
Net income | -25.66M | 20.91% |
Net profit margin | — | — |
Earnings per share | -0.58 | 51.26% |
EBITDA | — | — |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 160.72M | 40.18% |
Total assets | 175.55M | 33.56% |
Total liabilities | 73.86M | 35.46% |
Total equity | 101.68M | — |
Shares outstanding | 54.45M | — |
Price to book | 16.90 | — |
Return on assets | -38.48% | — |
Return on capital | -43.79% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -25.66M | 20.91% |
Cash from operations | -25.14M | -18.82% |
Cash from investing | 18.56M | 38.10% |
Cash from financing | 24.83M | 19.89% |
Net change in cash | 18.24M | 40.48% |
Free cash flow | -17.42M | -74.75% |
About
Founded
2016
Headquarters
Website
Employees
51
